The short version of Fatty diacid fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2025-11-18. Anything still debated is marked as such rather than presented as settled.
Structural work on the molecule centers on a C20 fatty diacid moiety attached through a linker to the peptide backbone. This side chain promotes reversible binding to serum albumin, which slows renal clearance and supports a prolonged action profile. The peptide backbone incorporates aminoisobutyric acid substitutions that limit recognition by digestive enzymes. Together these modifications produce a molecule that is stable enough for subcutaneous delivery but still dependent on careful manufacturing control. Analytical characterization of the active pharmaceutical ingredient typically follows the conventions used for other synthetic peptides.
Tirzepatide is a synthetic peptide composed of 39 amino acids. It acts as a dual agonist at two incretin receptors, the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor. The molecule was designed by modifying the native sequence of glucose-dependent insulinotropic polypeptide to improve metabolic stability and extend its circulation time. Its structure includes several non-natural amino acid residues and a fatty acid side chain. These features distinguish it from earlier single-receptor incretin analogs studied in the same period.
An extended fatty diacid moiety promotes binding to serum albumin, which slows renal clearance and extends the circulating half-life to roughly five days. That property supports once-weekly administration and largely explains the dosing interval described in clinical reports. Published data come mainly from large randomised programmes that evaluated glycaemic control and body weight over periods of many months. Long-term outcomes beyond those trial windows, including what happens after treatment stops, remain an active area of investigation.
Tirzepatide is a synthetic peptide built from thirty-nine amino acids. Its sequence is derived from native glucose-dependent insulinotropic polypeptide, or GIP, with several non-natural residues and a fatty diacid side chain attached through a linker. The molecule behaves as a dual agonist at two incretin receptors, GIP and GLP-1, instead of targeting a single receptor. This dual engagement separates it from earlier single-receptor incretin compounds and underpins most of its reported pharmacological activity.
At the receptor level, the compound binds both GIP and GLP-1 receptors and triggers downstream signalling that raises cyclic AMP in target cells. GLP-1 receptor activation is associated with glucose-dependent insulin release, slower gastric emptying, and reduced appetite signalling. GIP receptor activation contributes effects that are less completely characterised, and how much each receptor adds to the overall clinical response is still an open question. The two pathways appear to interact in a complementary rather than a purely additive way.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Dual incretin receptor agonist |
| Amino acid count | 39 residues | Includes non-natural residues |
| Approximate mass | 4.8 kDa | Reported values vary slightly by source |
| Fatty acid component | C20 diacid | Supports albumin binding |
| First US approval | 2022 | Glycemic indication, weight management followed |
Development began in the 2010s, when researchers modified a GIP-based scaffold to add GLP-1 activity and then attached the fatty diacid to lengthen its half-life. Clinical evaluation proceeded through large phase 3 programmes in type 2 diabetes and in obesity, and regulators in the United States cleared the compound for type 2 diabetes in 2022 and for chronic weight management in 2023. Several cardiovascular and metabolic outcome studies are still reporting, so the picture of long-term benefit and risk is incomplete. Approvals in other regions followed on different timelines.
Tirzepatide is a synthetic peptide of 39 amino acids that carries a C20 fatty diacid side chain attached through a linker. Its molecular formula is C225H348N48O68, and its molecular weight is about 4813 daltons. The compound belongs to the incretin mimetic class and is administered by subcutaneous injection. The fatty acid chain promotes binding to serum albumin, which slows renal clearance and extends the circulation time of the molecule. It was identified during screening of sequences derived from glucose-dependent insulinotropic polypeptide.
Tirzepatide activates both the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor, making it a dual agonist rather than a selective agent. Engagement of the GLP-1 receptor is linked to glucose-dependent insulin release, slower gastric emptying, and reduced appetite signalling. The relative contribution of the GIP arm remains an active research question; proposed roles include improved insulin sensitivity and altered adipose tissue handling. Receptor occupancy studies suggest the molecule interacts with both targets at circulating concentrations achieved during therapy.
Dual agonism at the GIP and GLP-1 receptors underlies the observed pharmacology. Activation of GLP-1 receptors raises glucose-dependent insulin release, lowers glucagon secretion, slows gastric emptying and reduces appetite. GIP receptor activation contributes additional effects on adipose tissue and on energy balance, and the combined action on appetite appears larger than either pathway alone in animal models. Signalling bias and the relative contribution of each receptor arm to weight-related effects remain areas of active investigation.
Structure-activity work shows that fatty acid length, linker chemistry and the position of acylation all influence albumin affinity and receptor potency. Plasma protein binding exceeds 99 percent, which restricts distribution and slows renal clearance. Degradation proceeds largely through general proteolysis and fatty acid oxidation rather than cytochrome P450 metabolism, so exposure to common oxidative drug interactions is limited. Whether these clearance routes vary meaningfully between individuals is not fully established.
The molecule is a synthetic 39-amino-acid peptide whose backbone derives from the sequence of human glucose-dependent insulinotropic polypeptide, with several substitutions that raise metabolic stability and shift receptor preference. A C20 fatty diacid is attached through a short linker to a lysine side chain, a modification that increases binding to serum albumin. The reported monoisotopic mass is approximately 4813 Da. Near neutral pH the peptide carries a net negative charge, and the lipid tail makes the molecule markedly more hydrophobic than the unmodified parent sequence.
Research and analytical settings increasingly require documentation of peptide origin and chain of custody. Certificate of analysis documents typically report purity by chromatographic area, mass confirmation, appearance, and residual solvent or counterion content. Independent verification by an accredited laboratory is common when a material will be used in a regulated study. Open questions remain about how well compendial methods transfer between laboratories, and about which impurity thresholds are meaningful for materials not intended for clinical use.
Peptide-based pharmaceutical products such as tirzepatide require controlled temperature management to preserve structural integrity. Manufacturer labeling generally specifies refrigeration at 2 to 8 degrees Celsius before first use, with protection from light and freezing. Exposure to repeated temperature cycling can promote aggregation or deamidation, which alters the analytical profile even when the visible solution appears unchanged. Once a product is in use, the permitted storage window and temperature range are defined by the specific labeled presentation rather than by general peptide rules.
21 October – Stephen Flynn, the SNP's leader at Westminster, tables a motion urging the UK government to formally strip Prince Andrew of his royal titles following allegations made against him in the memoirs of Virginia Giuffre. A third, unnamed member of the grooming gang inquiry panel, resigns. Reform UK elects a new leader and deputy leader on Cornwall Council. 22 October – Angela Rayner gives her formal resignation speech to the House of Commons after leaving the frontbench. Jim Gamble becomes the second chair of the grooming gang inquiry to resign, while a fourth member resigns from the inquiry's panel as Starmer tells Prime Minister's Questions that the inquiry will look at racial and religious motives. King Charles and Queen Camilla arrive in Rome ahead of a historic state visit to Vatican City, where they will meet Pope Leo XIV. Reform UK's Linden Kemkaran issues a statement calling for councillors to back her in writing following advice to do so from her party's headquarters. 3 Labour members of Swindon Borough Council defect to the Green Party of England and Wales. 23 October – Lindsay Whittle wins the 2025 Caerphilly by-election for Plaid Cymru, taking the seat from Labour, who had held it since the Senedd was established in 1999. The UK government says it will not give MPs parliamentary time to debate whether Prince Andrew should be stripped of his titles. 24 October – 3 Scottish Green councillors defect to Jeremy Corbyn's Your Party, giving the party its first Scottish representatives.
The Accokeek Academy Capitol Heights Elementary School Glenarden Woods Elementary School Heather Hills Elementary School Highland Park Elementary School Longfields Elementary School Valley View Elementary School Greenbelt Middle School Kenmoor Middle School Walker Mill Middle School
==== Ireland ==== On May 13, 2025, it was announced that the first Taco Bell restaurant in Ireland would open in the summer of the same year in partnership with Applegreen, with more locations to follow. The first restaurant opened on 16 September 2025 in a new motorway service station off Junction 6 on the M3 in Dunshaughlin, County Meath.
== Biography == Franciszek Gajowniczek, a Roman Catholic, was born in Strachomin near Mińsk Mazowiecki. After the reconstitution of sovereign Poland, he moved to Warsaw in 1921, married, and had two sons. He was a professional soldier, a Polish army sergeant, who took part in the defense of Wieluń as well as Warsaw in September 1939 during the 1939 invasion of Poland by Nazi Germany. After the Battle of Modlin Gajowniczek was captured by the Gestapo in Zakopane while crossing the border into Slovakia and sentenced to forced labour in Tarnów.
== Causes == Link rot can result for several reasons. A target web page may be removed. The server that hosts the target page could fail, be removed from service, or relocate to a new domain name. As far back as 1999, it was noted that with the amount of material that can be stored on a hard drive, "a single disk failure could be like the burning of the library at Alexandria." A domain name's registration may lapse or be transferred to another party. Some causes will result in the link failing to find any target and returning an error such as HTTP 404. Other causes will cause a link to target content other than that which was intended by the link's author. Other reasons for broken links include:
Sources: en.wikipedia.org
Outside the centre stands a bronze statue of Thomas, by John Doubleday. Another monument to Thomas stands in Cwmdonkin Park, one of his favourite childhood haunts, close to his birthplace. The memorial is a small rock in an enclosed garden within the park cut by and inscribed by the late sculptor Ronald Cour with the closing lines from "Fern Hill".
the local conditions for initial crack growth which include the nucleation, growth, and coalescence of voids (decohesion) at a crack tip. a global energy balance criterion for further crack growth and unstable fracture.
== Society and culture == Fibromyalgia causes substantial economic and societal strain due to disability, reduced work hours, informal care, early retirement, and healthcare utilization. According to a 2014 review indirect costs, such as those due to disability and lost productivity, accounted for most of the costs, and the cost to society amounted to "tens of thousands of dollars each year" per patient. A 2022 review of 36 studies found that fibromyalgia causes a significant economic strain on healthcare systems. Annual costs per patient were estimated to be $1,750 to $35,920 in the US, and $1,250 to $8,504 in Europe. People with fibromyalgia can be subjected to significant stigma in society generally, and within the medical system. They may face disbelief in the legitimacy of their pain, moralizing attitudes, and suspicions of malingering, which relate to the invisible nature of the pain and prejudices relating to the historic predominance of women amongst people with the condition. Health professionals may hold negative attitudes towards patients with fibromyalgia, considering them "demanding" or their symptoms to be exaggerated or fake, and they may lack knowledge about the condition, which can also contribute to delays in diagnosis. Many people with fibromyalgia feel that healthcare providers believe they are faking or exaggerating. This stigma can have a considerable impact on the social interactions, trust in healthcare, and mental health of people with fibromyalgia.
For McArdle disease (GSD-V), regular aerobic exercise utilizing "second wind" to enable the muscles to become aerobically conditioned, as well as anaerobic exercise that follows the activity adaptations so as not to cause muscle injury, helps to improve exercise intolerance symptoms and maintain overall health. Studies have shown that regular low-moderate aerobic exercise increases peak power output, increases peak oxygen uptake (VO2peak), lowers heart rate, and lowers serum CK in individuals with McArdle disease. Regardless of whether the patient experiences symptoms of muscle pain, muscle fatigue, or cramping, the phenomenon of second wind having been achieved is demonstrable by the sign of an increased heart rate dropping while maintaining the same speed on the treadmill. Inactive patients experienced second wind, demonstrated through relief of typical symptoms and the sign of an increased heart rate dropping, while performing low-moderate aerobic exercise (walking or brisk walking). Conversely, patients that were regularly active did not experience the typical symptoms during low-moderate aerobic exercise (walking or brisk walking), but still demonstrated second wind by the sign of an increased heart rate dropping. For the regularly active patients, it took more strenuous exercise (very brisk walking/jogging or bicycling) for them to experience both the typical symptoms and relief thereof, along with the sign of an increased heart rate dropping, demonstrating second wind.
=== United States plan === Immediate ceasefire: An immediate end to hostilities between the US (and Israel) and Iran. Two-phase agreement structure: Reopening the Strait of Hormuz: Iran must immediately reopen the Strait of Hormuz, restoring global oil flow. Guaranteed maritime security: Creating a regional framework ensuring safe navigation through the Strait of Hormuz. Nuclear constraints on Iran: Iran commits to stop its alleged pursuit of nuclear weapons as part of the final deal Sanctions relief (conditional): The US signaled willingness to ease sanctions, but only in exchange for Iranian concessions. Release of frozen Iranian assets: Part of incentives included unfreezing Iranian funds abroad Structured negotiations via mediators: All talks will be channeled through Pakistan initially, then finalized in Islamabad. Possible extended ceasefire window: During Phase 2 the discussions will be over a period of 45 days. Broader regional de-escalation: The agreement aims to stabilize additional conflicts in the Middle East, not just the war with Iran.
Sources: en.wikipedia.org
=== Transport of hydrogen ions === Some oxyhemoglobin loses oxygen and becomes deoxyhemoglobin. Deoxyhemoglobin binds most of the hydrogen ions as it has a much greater affinity for more hydrogen than does oxyhemoglobin.
Concanavalin+A at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Concanavalin+A+Receptors at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Concanavalin A structure Archived 2008-08-20 at the Wayback Machine World of Lectin, Gateway to lectins Proteopedia 1bxh con A in complex with methyl alpha1-2 mannobioside
In a broad academic audience, the concept of the evolution of the genetic code from its original ambiguous form to a well-defined ("frozen") code with the repertoire of 20 (+2) canonical amino acids is widely accepted. However, there are different opinions, concepts, approaches and ideas regarding how to best reproduce this process experimentally. Even models are proposed that predict "entry points" for synthetic amino acid invasion of the genetic code. Since 2001, 40 non-natural amino acids have been added into proteins by creating a unique codon (recoding) and a corresponding transfer-RNA:aminoacyl – tRNA-synthetase pair to encode it with diverse physicochemical and biological properties in order to be used as a tool to exploring protein structure and function or to create novel or enhanced proteins. H. Murakami and M. Sisido extended some codons to have four and five bases. Steven A. Benner constructed a functional 65th (in vivo) codon. In 2015 N. Budisa, D. Söll and co-workers reported the full substitution of all 20,899 tryptophan residues (UGG codons) with unnatural thienopyrrole-alanine in the genetic code of the bacterium E. coli. In 2016 the first stable semisynthetic organism was created. It was a (single cell) bacterium with two synthetic bases (called X and Y). The bases survived cell division. In 2017, researchers in South Korea reported that they had engineered a mouse with an extended genetic code that can produce proteins with unnatural amino acids. In May 2019, researchers reported the creation of a new "Syn61" strain of the E. coli bacteria.
Contact mechanics is the study of the deformation of solids that touch each other at one or more points. A central distinction in contact mechanics is between stresses acting perpendicular to the contacting bodies' surfaces (known as normal stress) and frictional stresses acting tangentially between the surfaces (shear stress). Normal contact mechanics or frictionless contact mechanics focuses on normal stresses caused by applied normal forces and by the adhesion present on surfaces in close contact, even if they are clean and dry. Frictional contact mechanics emphasizes the effect of friction forces. Contact mechanics is part of mechanical engineering. The physical and mathematical formulation of the subject is built upon the mechanics of materials and continuum mechanics and focuses on computations involving elastic, viscoelastic, and plastic bodies in static or dynamic contact. Contact mechanics provides necessary information for the safe and energy efficient design of technical systems and for the study of tribology, contact stiffness, electrical contact resistance and indentation hardness. Principles of contacts mechanics are implemented towards applications such as locomotive wheel-rail contact, coupling devices, braking systems, tires, bearings, combustion engines, mechanical linkages, gasket seals, metalworking, metal forming, ultrasonic welding, electrical contacts, and many others. Current challenges faced in the field may include stress analysis of contact and coupling members and the influence of lubrication and material design on friction and wear.
Sources: en.wikipedia.org
It activates both the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor. This dual activity separates it from agents that act on only one of the two receptors. The relative contribution of each receptor to clinical effects remains an open area of study.
United States approval for type 2 diabetes was granted in 2022, and a chronic weight management indication was added later. Approval timelines differ across other jurisdictions. Earlier human data came from phase 1 and phase 2 trials published before those decisions.
Native hormones are short-lived peptides that enzymes degrade within minutes. Tirzepatide carries non-natural residues and a fatty acid chain that resist this breakdown and extend circulation time. The result is a longer interval between administrations than the natural hormones could support.
It acts as a dual agonist at the GIP receptor and the GLP-1 receptor. This broader targeting profile distinguishes it from selective GLP-1 agonists, which engage only one receptor.